Cytarabine [clinicaltrials_resource:22c1374b2123aed8146827c85013eca8]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma [clinicaltrials:NCT00000689]Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members [clinicaltrials:NCT00000703]Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma [clinicaltrials:NCT00000801]Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients [clinicaltrials:NCT00001048]Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00002481]clinicaltrials:NCT00002524clinicaltrials:NCT00002571Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002798]Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002800]clinicaltrials:NCT00002805clinicaltrials:NCT00002812clinicaltrials:NCT00002816High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies [clinicaltrials:NCT00002818]clinicaltrials:NCT00002833clinicaltrials:NCT00002835High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00002945]506U78 in Treating Patients With Refractory Hematologic Cancer [clinicaltrials:NCT00002970]Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors [clinicaltrials:NCT00003073]Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma [clinicaltrials:NCT00003079]Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia [clinicaltrials:NCT00003190]clinicaltrials:NCT00003239Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00003405]Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00003407]clinicaltrials:NCT00003593Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma [clinicaltrials:NCT00003632]Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase [clinicaltrials:NCT00003694]clinicaltrials:NCT00003700Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia [clinicaltrials:NCT00003934]Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00004215]clinicaltrials:NCT00004217clinicaltrials:NCT00004228clinicaltrials:NCT00004263Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus [clinicaltrials:NCT00004643]Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [clinicaltrials:NCT00004862]clinicaltrials:NCT00005585clinicaltrials:NCT00005596clinicaltrials:NCT00005601A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide [clinicaltrials:NCT00005793]Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma [clinicaltrials:NCT00005803]clinicaltrials:NCT00005977
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Cytarabine [clinicaltrials_resource:22c1374b2123aed8146827c85013eca8]
Bio2RDF identifier
22c1374b2123aed8146827c85013eca8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:22c1374b2123aed8146827c85013eca8
identifier
clinicaltrials_resource:22c1374b2123aed8146827c85013eca8
title
Cytarabine
@en
type
label
Cytarabine [clinicaltrials_resource:22c1374b2123aed8146827c85013eca8]
@en